Search Results - "De Leij, Lou F. M. H."

Refine Results
  1. 1

    Kinetics of US28 Gene Expression during Active Human Cytomegalovirus Infection in Lung-Transplant Recipients by Boomker, Jasper M., Verschuuren, Erik A. M., Brinker, Marja G. L., de Leij, Lou F. M. H., The, T. Hauw, Harmsen, Martin C.

    Published in The Journal of infectious diseases (01-06-2006)
    “…Targeting viral proteins early during infection may limit exacerbation of human cytomegalovirus infection. The viral chemokine-receptor homologue US28…”
    Get full text
    Journal Article
  2. 2

    In vivo characteristics of cationic liposomes as delivery vectors for gene therapy by AUDOUY, Sandrine A. L, DE LEIJ, Lou F. M. H, HOEKSTRA, Dick, MOLEMA, Grietje

    Published in Pharmaceutical research (01-11-2002)
    “…After a decade of clinical trials, gene therapy seems to have found its place between excessive ambitions and feasible aims, with encouraging results obtained…”
    Get full text
    Journal Article
  3. 3

    Epithelial Cell Adhesion Molecule: More than a Carcinoma Marker and Adhesion Molecule by Trzpis, Monika, McLaughlin, Pamela M.J, de Leij, Lou M.F.H, Harmsen, Martin C

    Published in The American journal of pathology (01-08-2007)
    “…The epithelial cell adhesion molecule (EpCAM, CD326) is a glycoprotein of approximately 40 kd that was originally identified as a marker for carcinoma,…”
    Get full text
    Journal Article
  4. 4

    EpCAM in carcinogenesis: the good, the bad or the ugly by van der Gun, Bernardina T.F., Melchers, Lieuwe J., Ruiters, Marcel H.J., de Leij, Lou F.M.H., McLaughlin, Pamela M.J., Rots, Marianne G.

    Published in Carcinogenesis (New York) (01-11-2010)
    “…The epithelial cell adhesion molecule (EpCAM) is a membrane glycoprotein that is highly expressed on most carcinomas and therefore of potential use as a…”
    Get full text
    Journal Article
  5. 5

    Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells by Bremer, Edwin, de Bruyn, Marco, Samplonius, Douwe F., Bijma, Theo, ten Cate, Bram, de Leij, Lou F. M. H., Helfrich, Wijnand

    “…Previously, we have shown that epidermal growth factor receptor (EGFR)-selective delivery of soluble tumor necrosis factor-related apoptosis-inducing ligand…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Polymorphic drug metabolism (CYP2D6) and utilisation of psychotropic drugs in hospitalised psychiatric patients: a retrospective study by TAMMINGA, Wim J, WEMER, Johan, OOSTERHUIS, Berend, DE BOER, Anthonius, VRANCKX, Stan, DRENTH, Ben F. H, DE ZEEUW, Rokus A, DE LEIJ, Lou F. M. H, JONKMAN, Jan H. G

    Published in European journal of clinical pharmacology (01-05-2003)
    “…The aim of the current retrospective study was to assess the influence of polymorphic drug metabolism as assessed by genotyping, on the on the utilisation of…”
    Get full text
    Journal Article
  8. 8

    CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemia by Bremer, Edwin, Cate, Bram ten, Samplonius, Douwe F., de Leij, Lou F.M.H., Helfrich, Wijnand

    Published in Blood (01-04-2006)
    “…Agonistic anti-Fas antibodies and multimeric recombinant Fas ligand (FasL) preparations show high tumoricidal activity against leukemic cells, but are…”
    Get full text
    Journal Article
  9. 9

    Serum insensitive, intranuclear protein delivery by the multipurpose cationic lipid SAINT-2 by VAN DER GUN, Bernardina T. F, MONAMI, Amélie, MCLAUGHLIN, Pamela M. J, LAARMANN, Sven, RASKO, Tamas, SLASKA-KISS, Krystyna, WEINHOLD, Elmar, WASSERKORT, Reinhold, DE LEIJ, Lou F. M. H, RUITERS, Marcel H. J, KISS, Antal

    Published in Journal of controlled release (20-11-2007)
    “…Cationic liposomal compounds are widely used to introduce DNA and siRNA into viable cells, but none of these compounds are also capable of introducing…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    The Role of B Cell-Mediated T Cell Costimulation in the Efficacy of the T Cell Retargeting Bispecific Antibody BIS20x3 by Stel, Alja J, Kroesen, Bart-Jan, Jacobs, Susan, Groen, Herman, de Leij, Lou F. M. H, Kluin-Nelemans, Hanneke C, Withoff, Sebo

    Published in The Journal of immunology (1950) (15-11-2004)
    “…In this study, we investigated the role of the naturally occurring B cell-mediated T cell costimulation in the antitumor efficacy of the bispecific Ab BIS20x3…”
    Get full text
    Journal Article
  13. 13

    Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer by Kok, Klaas, Osinga, Jan, Carritt, Ben, Davis, Mary B, van der Hout, Annemarie H, van der Veen, Anneke Y, Landsvater, Rudy M, de Leij, Lou F. M. H, Berendsen, Henk H, Postmus, Pieter E, Poppema, Sibrand, Buys, Charles H. C. M

    Published in Nature (London) (10-12-1987)
    “…In childhood malignancies such as retinoblastoma and Wilms tumour, of which both familial and sporadic forms exist, recessive mutations of presumed…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for obliterative airway disease by NING QU, DE BRAN, Aalzen, HARMSEN, Martin C, KROESE, Frans G. M, DE LEIJ, Lou F. M. H, PROP, Jochum

    Published in Transplantation (15-10-2003)
    “…Immune injury to airway epithelium is suggested to play a central role in the pathogenesis of obliterative bronchiolitis (OB) after clinical lung…”
    Get full text
    Journal Article
  16. 16

    BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome by Kroesen, Bart-Jan, Jacobs, Susan, Pettus, Benjamin J., Sietsma, Hannie, Kok, Jan Willem, Hannun, Yusuf A., de Leij, Lou F.M.H.

    Published in The Journal of biological chemistry (25-04-2003)
    “…In this study, we describe an ordered formation of long- and very long-chain ceramide species in relation to the progression of B-cell receptor (BcR)…”
    Get full text
    Journal Article
  17. 17

    EpCAM in morphogenesis by Trzpis, Monika, Bremer, Edwin, McLaughlin, Pamela M J, de Leij, Lou F M H, Harmsen, Martin C

    Published in Frontiers in bioscience (01-05-2008)
    “…Embryonic development is one of the most complex biological phenomena that involves the appropriate expression and synchronized interactions of a plethora of…”
    Get full text
    Journal Article
  18. 18

    Distribution patterns of the membrane glycoprotein CD44 during the foreign-body reaction to a degradable biomaterial in rats and mice by Bonnema, Harmke, Popa, Eliane R, van Timmeren, Mirjan M., van Wachem, Pauline B., de Leij, Lou F. M. H., van Luyn, Marja J. A.

    “…Although biomaterials have been used in the clinical setting for a long time, little is known of the molecular mechanisms underlying the foreign‐body reaction…”
    Get full text
    Journal Article
  19. 19

    Mephenytoin as a probe for CYP2C19 phenotyping:effect of sample storage, intra‐individual reproducibility and occurrence of adverse events by Tamminga, Wim J., Wemer, Johan, Oosterhuis, Berend, Wieling, Jaap, Touw, Daan J., De Zeeuw, Rokus A., De Leij, Lou F. M. H., Jonkman, Jan H. G.

    Published in British journal of clinical pharmacology (01-05-2001)
    “…Aims  To further evaluate mephenytoin as a probe for CYP2C19 phenotyping. Methods  Healthy subjects (n = 2638) were phenotyped using the urinary…”
    Get full text
    Journal Article
  20. 20

    The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer by Boomker, Jasper M., The, T. Hauw, de Leij, Lou F.M.H., Harmsen, Martin C.

    Published in Virus research (01-06-2006)
    “…The activation of the major immediate-early promoter (MIEP) is a key event in the cytomegalovirus replication cycle and is dependent on cellular transcription…”
    Get full text
    Journal Article